Hosted on MSN
Windtree Therapeutics Cuts Preferred Stock by Over 99% Ahead of Crypto Strategy Rollout
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced major reductions in its outstanding Series C and Series D preferred shares, positioning the company to limit future equity ...
Windtree Therapeutics’ high-profile plan to raise up to $200 million for a BNB BNB $1,151.89 treasury has run headlong into a market reality check: the Nasdaq is kicking it off the exchange. The ...
Windtree expected to become a leader and the first NASDAQ-listed company offering direct exposure to the Binance Smart Chain Ecosystem (BNB) WARRINGTON, Pa., July 16, 2025 (GLOBE NEWSWIRE) -- Windtree ...
Nasdaq-listed biotech firm Windtree Therapeutics has entered into a strategic partnership with crypto exchange Kraken to manage its BNB-focused crypto treasury program, the companies announced Tuesday ...
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has entered into a strategic partnership with Kraken, a leading global cryptocurrency platform, to support custody, trading, and ...
Windtree Therapeutics, Inc. (NASDAQ: WINT), a healthcare company based in Warrington, Pennsylvania, has decided to execute a significant strategic pivot. The landmark deal includes the potential to ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Windtree Therapeutics has ...
Windtree Therapeutics saw its shares collapse on Wednesday after Nasdaq said it would delist the biotech for failing to comply with listing standards. Windtree Therapeutics' stock collapsed 77% after ...
WARRINGTON, Pa., July 22, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT) is pleased to announce a strategic partnership with Kraken, a leading ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Windtree Therapeutics' latest ...
WARRINGTON, Pa., July 16, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc (WINT). (“Windtree” or the “Company”) (NasdaqCM: WINT) is excited to announce it has entered into a $60 million securities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results